Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dropless Prophylaxis vs Standard Drops in Cataract Surgery
NCT02515045Phase 4Completed
- Sponsor
- Carolina Eyecare Physicians
- Start
- Jan 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Imprimis Dropless in cataract (3 arms), sponsored by Carolina Eyecare Physicians. Primary endpoint: Change From Baseline in Macular Thickness at Month 1. Started Jan 2015; status: completed.
02
Drugs
Imprimis Dropless
03
Conditions
cataract
Beyond the preview
Go deeper on NCT02515045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02515045.